These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32031716)

  • 1. Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis.
    Gkalpakiotis S; Arenberger P; Skalicka P; Arenbergerova M
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e281-e283. PubMed ID: 32031716
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular surface disease associated with dupilumab treatment for atopic diseases.
    Utine CA; Li G; Asbell P; Pflugfelder S; Akpek E
    Ocul Surf; 2021 Jan; 19():151-156. PubMed ID: 32439390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limbic Keratoconjunctivitis Associated With Dupilumab Treatment in Atopic Dermatitis.
    Lin RY; Sun G
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2450-2451. PubMed ID: 35931626
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis.
    Cheng J; Jiang L; Morrow NC; Avdic A; Fairley JA; Ling JJ; Greiner MA
    J Am Acad Dermatol; 2021 Jul; 85(1):265-267. PubMed ID: 32956738
    [No Abstract]   [Full Text] [Related]  

  • 5. Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment.
    Nahum Y; Mimouni M; Livny E; Bahar I; Hodak E; Leshem YA
    Br J Ophthalmol; 2020 Jun; 104(6):776-779. PubMed ID: 31554632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Keratoconjunctivitis associated with atopic dermatitis treated with tocilizumab].
    Raga Jiménez C; Álvarez Martín T; Ferrando Piqueres R; Pitarch Bort G
    Farm Hosp; 2018 Jan; 42(1):29-30. PubMed ID: 29306313
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.
    Brodska P; Panzner P; Sedlacek D; Terl M; Cetkovska P
    Dermatol Ther; 2020 Nov; 33(6):e14159. PubMed ID: 32776586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopic keratoconjunctivitis alleviated with dupilumab.
    Chen J; Bielory L
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):375-376. PubMed ID: 35671933
    [No Abstract]   [Full Text] [Related]  

  • 11. Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.
    Blakely K; Gooderham M; Papp K
    Skin Therapy Lett; 2016 Mar; 21(2):1-5. PubMed ID: 27223113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis.
    Rohner MH; Thormann K; Cazzaniga S; Yousefi S; Simon HU; Schlapbach C; Simon D
    Allergy; 2021 Apr; 76(4):1268-1270. PubMed ID: 33210741
    [No Abstract]   [Full Text] [Related]  

  • 13. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
    Simpson EL; Bieber T; Guttman-Yassky E; Beck LA; Blauvelt A; Cork MJ; Silverberg JI; Deleuran M; Kataoka Y; Lacour JP; Kingo K; Worm M; Poulin Y; Wollenberg A; Soo Y; Graham NM; Pirozzi G; Akinlade B; Staudinger H; Mastey V; Eckert L; Gadkari A; Stahl N; Yancopoulos GD; Ardeleanu M;
    N Engl J Med; 2016 Dec; 375(24):2335-2348. PubMed ID: 27690741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
    Kraft M; Worm M
    Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe atopic dermatitis effectively treated with dupilumab changed from interleukin-5 inhibitors for concomitant severe bronchial asthma.
    Ichiyama S; Ito M; Hoashi T; Kanda N; Natsuno T; Saeki H
    J Dermatol; 2021 Feb; 48(2):e76-e77. PubMed ID: 33161609
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis.
    Ferrillo M; Patruno C; Villani A; Scalvenzi M; Fabbrocini G; D'Andrea M; Napolitano M
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e701-e703. PubMed ID: 32239552
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis.
    Chello C; Sernicola A; Paolino G; Grieco T
    An Bras Dermatol; 2021; 96(5):638-640. PubMed ID: 34275694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyenthesitis during treatment with dupilumab for atopic dermatitis.
    Ishibashi M; Honda T; Tabuchi Y; Kabashima K
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e319-e321. PubMed ID: 31991016
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of Dupilumab in two patients with severe and recalcitrant atopic dermatitis previously treated with extracorporeal photopheresis.
    Russo F; Taddeucci P; Lazzeri L; Flori ML; Rubegni P
    Dermatol Ther; 2020 May; 33(3):e13284. PubMed ID: 32092216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.